Strontium ranelate and Profen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strontium ranelate (strontium ranelate) and Profen (ibuprofen). Common drug interactions include toxic skin eruption among females.

The phase IV clinical study analyzes what interactions people have when they take Strontium ranelate and Profen. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Strontium ranelate?

Strontium ranelate has active ingredients of strontium ranelate. eHealthMe is studying from 447 Strontium ranelate users. Check the latest studies of Strontium ranelate.

What is Profen?

Profen has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 245,311 Profen users. Check the latest studies of Profen.

On Jul, 26, 2026

14 people who take Strontium ranelate and Profen together, and have interactions are studied.

Strontium ranelate and Profen drug interactions.

What are the common drug interactions of Strontium Ranelate and Profen, by gender? *:

female:

Toxic skin eruption (skin breakdown due to toxic substance)
Anaemia (lack of blood)
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site pain
Loss of consciousness
Mobility decreased (ability to move is reduced)
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)
Weight decreased

male:

n/a

What are the common drug interactions of Strontium Ranelate and Profen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Renal failure acute (rapid kidney dysfunction)
Injection site haematoma (localized swelling filled with blood at injection site)
Injection site pain
Renal failure (kidney dysfunction)

50-59:

Toxic skin eruption (skin breakdown due to toxic substance)

60+:

Anaemia (lack of blood)
Bronchopneumonia (inflammation of the lungs, arising in the bronchi or bronchioles)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Gastrointestinal dysplasia (developmental defect of gastrointestinal tract)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Herpes zoster

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 14.29%
Osteoporosis (bones weak and more likely to break): 2 people, 14.29%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Pneumonia: 1 person, 7.14%
Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up): 1 person, 7.14%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 7.14%
Metastases To Bone (cancer spreads to bone): 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Strontium ranelate and Profen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously